July 2024 Issue

Watch for Resmetirom to Treat NASH

Resmetirom (Rezdiffra) will be the first med approved for treatment of nonalcoholic steatohepatitis (NASH) with fibrosis in adults...

GO TO FULL ISSUE

What is Prescriber Insights: APRN?

Prescriber Insights: APRN is the fastest, most trustworthy way for advanced practice nurses to find out how drug therapy changes should fit into your practice. It's unbiased, evidence-based, and 100% free from financial support of the pharma industry. Learn more >


NetCE. A TRC Healthcare Brand. All Access: PA. Easily Meet State Mandates. Get unlimited access to 1,500+ hours of CME that meets state mandates exclusively for APRNs. Learn More

Unlock More

Prescriber Insights: APRN is one of many medication advisory and CE solutions from TRC Healthcare for advanced practice nurses. Learn more about:


Group Purchases & Pricing

Prescriber Insights: APRN is eligible for bulk discounts. Easy for admins to manage access, easy for staff to track CE mandates and earn pharmacology credit. Plus, bundle and save. Request information